EFDID: 26264EFD: View Filing

Issuer: Cahaba Pharmaceuticals, LLC (0001460300) - D

Accession: 0001460300-10-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001460300
  • Entity Name:
    Cahaba Pharmaceuticals, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2008)
  • Address:
    103 Carnegie Center, Suite 300
    Princeton, NJ 08540
  • Persons:
    Related Persons 4
    Andrew P Aromando
    Executive Officer
    William M Testa
    Executive Officer
    Madding King, III
    DirectorPromoter
    J. Rainer Twiford
    DirectorPromoter
EDGAR: Offering Information
  • Accession Date:
    10/27/2010
  • First Sale Date:
    10/20/2010
  • Offering Amount:
    $1,500,000
  • Amount Sold:
    $500,000
  • Amount Remaining:
    $1,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
N/A None None None AL, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cahaba Pharmaceuticals, LLCMichel M. MarcouxMichel M. MarcouxAuthorized Company Signatory by POA2010-10-27